# Sprint 1, Day 1 - Completion Checklist

## Purpose and status

This checklist records whether the Day 1 product-framing artifacts are documented and internally aligned. A checked item means the stated documentation exists in the cited artifact. It does **not** claim user research, implementation, testing, clinical validation, production readiness or achieved outcomes.

## Product and workflow boundary

- [x] **Documented** - The MVP start is a diagnostic order for the synthetic Asha Mehta episode. The end is a human-confirmed next safe care step. [Product Case Foundation](product_case_foundation.md) and [MVP Scope Boundary](mvp_scope.md)
- [x] **Documented** - The primary workflow is diagnostic order -> result available -> clinician acknowledgement -> follow-up direction -> next step confirmed. [Product Case Foundation](product_case_foundation.md)
- [x] **Documented** - A result being available is explicitly distinct from clinical review and acknowledgement. [Current-State Workflow](current_state_workflow.md) and [Future-State Workflow](future_state_workflow.md)
- [x] **Documented** - Allowed end paths are clinic management, day-care referral and hospital escalation with financial preparation beginning where required. [MVP Scope Boundary](mvp_scope.md) and [Care-Episode State Model](care_episode_state_model.md)
- [x] **Documented** - Surgery, discharge and home recovery are deferred. [MVP Scope Boundary](mvp_scope.md)

## Control, safety and traceability

- [x] **Documented** - Uncertain patient, encounter or event linkage routes to reconciliation and is never silently attached. [Care-Episode State Model](care_episode_state_model.md) and [State Transition Table](state_transition_table.csv)
- [x] **Documented** - System actions, AI-assisted actions and human decisions are visibly separated. [Future-State Workflow](future_state_workflow.md) and [Care-Episode State Model](care_episode_state_model.md)
- [x] **Documented** - Clinical review, acknowledgement, follow-up direction, referral approval, referral acceptance where required, financial authorisation and amended-result re-review remain human-controlled. [Care-Episode State Model](care_episode_state_model.md)
- [x] **Documented** - Financial readiness is supporting work on selected escalation paths and does not autonomously approve care or independently confirm a next step. [MVP Scope Boundary](mvp_scope.md)
- [x] **Documented** - Source linkage, approval/rejection/correction logging, audit history and minimum-necessary synthetic-data handling are explicit. [Future-State Workflow](future_state_workflow.md) and [Measurement and Evidence](success_metrics.md)

## AI, exceptions and validation boundaries

- [x] **Documented** - The two MVP AI capabilities have defined boundaries: source-linked episode summary; and a referral handoff draft activated only after human-approved referral or escalation. Operational-attention recommendations are roadmap or optional evaluation material. [Future-State Workflow](future_state_workflow.md) and [MVP Scope Boundary](mvp_scope.md)
- [x] **Documented** - Deterministic rules manage missing owner, missed SLA, overdue acknowledgement and duplicate-event indicators; AI does not replace those checks or prioritise clinical urgency. [MVP Scope Boundary](mvp_scope.md)
- [x] **Documented** - At least five synthetic failure scenarios are planned, including acknowledgement delay, uncertain linkage, incomplete result, amended result, referral rejection, missing administrative information and integration outage. [MVP Scope Boundary](mvp_scope.md)
- [x] **Documented** - Measurement definitions cover workflow outcome, path completion, patient communication, safety/data quality, auditability and AI evaluation without claiming results. [Measurement and Evidence](success_metrics.md)

## Registers and evidence discipline

- [x] **Documented** - Testable assumptions cover acknowledgement, ownership, exception handling, SMART-launch usability, AI assistance, financial prerequisites, patient communication, reconciliation and amended-result review. [Assumption Register](assumption_register.csv)
- [x] **Documented** - Product decisions record the overlay boundary, SMART on FHIR, diagnostic closure and care escalation, synthetic data, rules-versus-AI model, AI boundaries, human approval, architecture-only items and key metrics. [Decision Register](decision_register.csv)
- [x] **Documented** - Claims are separated from assumptions, pilot hypotheses, validation requirements, proposed capabilities and roadmap items. [Measurement and Evidence](success_metrics.md), [Assumption Register](assumption_register.csv) and [Decision Register](decision_register.csv)

## Day 2 readiness

- [x] **Ready to begin** - Day 2 may begin with requirements and screen-design planning because the Day 1 product boundary, workflow controls, scope, state model, failure-case plan and measurement definitions are documented.
- [ ] **Not yet evidenced** - User review, workflow validation, prototype implementation, failure-case execution and AI evaluation remain future work. They must not be described as complete until evidence exists.

## Day 1 handoff statement

Day 1 establishes a coherent, safety-bounded product case for the hypothetical ContinuumOS portfolio project. It freezes the diagnostic-closure MVP boundary and documents what must be validated next. It does not establish real-world clinical effectiveness, implementation readiness or production outcomes.
